Current Pharmaceutical Design
Title: Preface
Volume: 8 Issue: 5
Author(s): Ken Bradstock
Affiliation:
Export Options
About this article
Cite this article as:
Bradstock Ken, Preface, Current Pharmaceutical Design 2002; 8 (5) . https://dx.doi.org/10.2174/1381612023396069
DOI https://dx.doi.org/10.2174/1381612023396069 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Failure of Immunomodulation Therapy in Heart Failure: Does the Statins “Paradigm” Prove the Rule?
Current Vascular Pharmacology Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation
Current Pharmaceutical Biotechnology Effect of Dietary Education on Cardiovascular Risk Factors in Rheumatoid Arthritis Patients
Current Rheumatology Reviews Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies
Current Neuropharmacology Assessment of New E2 Protein Domain Interaction with PKR Protein to Control IFN Signaling
Current Proteomics Red Cell Membrane Lipids in Hemoglobinopathies
Current Molecular Medicine New Applications for Sublingual Immunotherapy in Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological and Clinical Applications of Natriuretic Peptides: Accepted Knowledges or Changing Views?
Current Pharmaceutical Analysis Neuron-Microglia Interaction in Neuroinflammation
Current Protein & Peptide Science The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia
Current Neurovascular Research Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins
Current Medicinal Chemistry Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches
Current Pharmaceutical Design Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Current Medicinal Chemistry Currently Used Biologic Agents in the Management of Behcet’s Syndrome
Current Medicinal Chemistry MicroRNA-155 Regulates Inflammatory Response in Ischemic Cerebral Tissues through Autophagy
Current Neurovascular Research Thiazoles and Thiazolidinones as Antioxidants
Current Medicinal Chemistry Patent Selections:
Recent Patents on Drug Delivery & Formulation Role of TARC/CCL17 and CTACK/CCL27 in the Pathogenesis of Atopic Dermatitis
Current Immunology Reviews (Discontinued)